Complete Filing Data
Beta Bionics, Inc. reported Stockholders Equity of $287.61 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Beta Bionics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Selling And Marketing Expense | $61.4M | $37.1M | $12.0M |
| Revenue From Contract With Customer Excluding Assessed Tax | $100.3M | $65.1M | $12.0M |
| Research And Development Expense | $34.8M | $26.2M | $17.9M |
| Other Nonoperating Income Expense | -$1.0K | -$2.0K | -$68.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $338.0K | -$72.0K | $137.0K |
| Operating Income Loss | -$71.7M | -$45.3M | -$35.9M |
| Operating Expenses | $127.2M | $81.1M | $42.2M |
| Nonoperating Income Expense | -$1.5M | -$9.5M | -$8.2M |
| Net Income Loss | -$73.2M | -$54.8M | -$44.1M |
| Gross Profit | $55.5M | $35.9M | $6.3M |
| General And Administrative Expense | $31.0M | $17.9M | $12.2M |
| Cost Of Goods And Services Sold | $44.7M | $29.2M | $5.7M |
| Comprehensive Income Net Of Tax | -$72.9M | -$54.8M | -$44.0M |
| Deferred Revenue Noncurrent | $3.3M | $1.9M | $255.0K |
| Deferred Revenue Current | $1.6M | $939.0K | $87.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Selling And Marketing Expense | $16.0M | $15.6M | $13.4M | $9.6M | $9.0M | $7.7M |
| Revenue From Contract With Customer Excluding Assessed Tax | $27.3M | $23.2M | $17.6M | $16.7M | $15.0M | $12.9M |
| Research And Development Expense | $8.2M | $8.9M | $7.6M | $5.1M | $6.4M | $5.5M |
| Other Nonoperating Income Expense | $1.0K | -$2.0K | $0.00 | -$4.0K | -$2.0K | $4.0K |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $205.0K | -$91.0K | $175.0K | $79.0K | -$26.0K | -$132.0K |
| Operating Income Loss | -$17.0M | -$19.9M | -$18.6M | -$11.0M | -$11.8M | -$9.5M |
| Operating Expenses | $32.2M | $32.4M | $27.6M | $19.9M | $19.9M | $16.7M |
| Nonoperating Income Expense | $2.8M | $3.0M | -$10.0M | $1.2M | -$2.7M | -$3.0M |
| Net Income Loss | -$14.2M | -$16.9M | -$28.7M | -$9.7M | -$14.5M | -$12.4M |
| Gross Profit | $15.1M | $12.5M | $9.0M | $8.9M | $8.1M | $7.2M |
| General And Administrative Expense | $7.9M | $7.9M | $6.6M | $5.1M | $4.5M | $3.5M |
| Cost Of Goods And Services Sold | $12.1M | $10.7M | $8.7M | $7.8M | $7.0M | $5.7M |
| Comprehensive Income Net Of Tax | -$14.0M | -$17.0M | -$28.5M | -$9.7M | -$14.5M | -$12.6M |
| Deferred Revenue Noncurrent | $3.0M | $2.7M | $2.3M | |||
| Deferred Revenue Current | $1.3M | $1.1M | $949.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $287.6M | -$245.4M | -$203.1M | -$170.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $31.7M | $30.5M | $26.7M | $27.8M |
| Cash And Cash Equivalents At Carrying Value | $31.6M | $30.4M | $26.6M | |
| Temporary Equity Liquidation Preference | $0.00 | $355.2M | $295.2M | |
| Short Term Investments | $187.5M | $73.1M | $70.2M | |
| Retained Earnings Accumulated Deficit | -$369.9M | -$296.7M | -$229.7M | |
| Restricted Cash | $100.0K | $100.0K | $100.0K | |
| Provision For Excess And Obsolete Inventory | $1.5M | -$636.0K | -$58.0K | |
| Property Plant And Equipment Net | $8.6M | $4.8M | $2.5M | |
| Prepaid Expense And Other Assets Current | $9.8M | $4.0M | $1.2M | |
| Other Assets Noncurrent | $180.0K | $150.0K | $121.0K | |
| Operating Lease Right Of Use Asset Amortization Expense | $1.3M | $1.1M | $865.0K | |
| Operating Lease Right Of Use Asset | $6.6M | $6.6M | $3.7M | |
| Operating Lease Liability Noncurrent | $5.4M | $5.7M | $3.0M | |
| Operating Lease Liability Current | $1.9M | $1.5M | $1.2M | |
| Liabilities Current | $30.9M | $21.1M | $10.6M | |
| Liabilities And Stockholders Equity | $328.7M | $149.6M | $110.0M | |
| Liabilities | $41.1M | $73.6M | $51.4M | |
| Inventory Net | $21.7M | $13.3M | $1.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.1M | $3.9M | -$1.1M | |
| Assets Current | $267.9M | $132.9M | $103.6M | |
| Assets | $328.7M | $149.6M | $110.0M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $403.0K | $65.0K | $137.0K | |
| Accrued Liabilities And Other Liabilities | $22.4M | $15.8M | $8.1M | |
| Accretion Of Discount On Short-Term Investments | -$2.1M | -$2.9M | -$747.0K | |
| Accounts Receivable Net Current | $17.1M | $12.0M | $4.4M | |
| Accounts Payable Current | $5.0M | $2.9M | $1.2M | |
| Restricted Cash Noncurrent | $100.0K | $100.0K | ||
| Non Cash Unrealized Gain Loss On Short Term Investments | -$72.0K | $137.0K | ||
| Gain Loss On Sale Of Property Plant Equipment | -$31.0K | -$23.0K | -$11.0K | |
| Warrant Liabilities Noncurrent | $44.9M | $37.6M | ||
| Temporary Equity Carrying Amount Attributable To Parent | $321.4M | $261.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $294.8M | $301.6M | $313.8M | -$228.8M | -$221.2M | -$214.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $38.6M | $35.2M | $42.6M | $17.6M | $13.1M | $22.2M |
| Cash And Cash Equivalents At Carrying Value | $38.5M | $35.1M | $42.5M | $17.5M | $13.0M | $22.1M |
| Temporary Equity Liquidation Preference | $0.00 | $0.00 | $0.00 | |||
| Short Term Investments | $190.2M | $214.6M | $189.0M | |||
| Retained Earnings Accumulated Deficit | -$356.5M | -$342.3M | -$325.4M | |||
| Restricted Cash | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Provision For Excess And Obsolete Inventory | $82.0K | -$23.0K | ||||
| Property Plant And Equipment Net | $7.4M | $6.5M | $5.5M | |||
| Prepaid Expense And Other Assets Current | $9.4M | $7.6M | $5.7M | |||
| Other Assets Noncurrent | $183.0K | $144.0K | $146.0K | |||
| Operating Lease Right Of Use Asset Amortization Expense | $301.0K | $276.0K | ||||
| Operating Lease Right Of Use Asset | $7.0M | $6.0M | $6.3M | |||
| Operating Lease Liability Noncurrent | $5.7M | $5.2M | $5.5M | |||
| Operating Lease Liability Current | $2.0M | $1.5M | $1.5M | |||
| Liabilities Current | $25.4M | $19.5M | $16.5M | |||
| Liabilities And Stockholders Equity | $330.0M | $330.0M | $338.0M | |||
| Liabilities | $35.3M | $28.3M | $24.3M | |||
| Inventory Net | $20.4M | $17.3M | $15.7M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $12.0M | -$4.5M | ||||
| Assets Current | $270.0M | $286.1M | $261.9M | |||
| Assets | $330.0M | $330.0M | $338.0M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $354.0K | $149.0K | $240.0K | |||
| Accrued Liabilities And Other Liabilities | $17.6M | $13.4M | $10.6M | |||
| Accretion Of Discount On Short-Term Investments | -$916.0K | -$875.0K | ||||
| Accounts Receivable Net Current | $11.5M | $11.4M | $9.1M | |||
| Accounts Payable Current | $4.5M | $3.4M | $3.5M | |||
| Restricted Cash Noncurrent | $100.0K | $100.0K | $100.0K | |||
| Non Cash Unrealized Gain Loss On Short Term Investments | $25.0K | -$132.0K | ||||
| Gain Loss On Sale Of Property Plant Equipment | -$8.0K | |||||
| Warrant Liabilities Noncurrent | ||||||
| Temporary Equity Carrying Amount Attributable To Parent |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $16.4M | $6.4M | $5.7M |
| Proceeds From Stock Options Exercised | $4.8M | $89.0K | $10.0K |
| Payments To Acquire Property Plant And Equipment | $5.3M | $3.4M | $402.0K |
| Net Cash Provided By Used In Operating Activities | -$50.9M | -$48.3M | -$32.4M |
| Net Cash Provided By Used In Investing Activities | -$162.8M | -$3.5M | -$69.7M |
| Net Cash Provided By Used In Financing Activities | $214.9M | $55.6M | $101.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.8M | $2.8M | $391.0K |
| Increase Decrease In Other Noncurrent Assets | $30.0K | $29.0K | $28.0K |
| Increase Decrease In Operating Lease Liability | -$1.2M | -$1.0M | -$948.0K |
| Increase Decrease In Inventories | $9.9M | $11.4M | $1.2M |
| Increase Decrease In Deferred Revenue | $2.1M | $2.5M | $342.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $7.4M | $6.8M | $1.8M |
| Increase Decrease In Accounts Receivable | $5.2M | $7.6M | $4.5M |
| Increase Decrease In Accounts Payable | $2.1M | $1.5M | $716.0K |
| Payments To Acquire Short Term Investments | $282.0M | $72.1M | $69.3M |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $170.0M | $72.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 |
|---|---|---|
| Share Based Compensation | $2.8M | $1.4M |
| Proceeds From Stock Options Exercised | $98.0K | $6.0K |
| Payments To Acquire Property Plant And Equipment | $333.0K | $406.0K |
| Net Cash Provided By Used In Operating Activities | -$20.0M | -$12.1M |
| Net Cash Provided By Used In Investing Activities | -$179.1M | $7.6M |
| Net Cash Provided By Used In Financing Activities | $211.1M | $6.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.6M | $1.1M |
| Increase Decrease In Other Noncurrent Assets | -$4.0K | -$1.0K |
| Increase Decrease In Operating Lease Liability | -$281.0K | -$224.0K |
| Increase Decrease In Inventories | $2.6M | $2.4M |
| Increase Decrease In Deferred Revenue | $480.0K | $549.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$5.3M | -$231.0K |
| Increase Decrease In Accounts Receivable | -$2.9M | $1.9M |
| Increase Decrease In Accounts Payable | -$97.0K | $410.0K |
| Payments To Acquire Short Term Investments | $142.9M | |
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $28.0M | $8.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 40.5M | 6.4M | 5.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 40.5M | 6.4M | 5.3M |
| Earnings Per Share Diluted | $-1.81 | $-8.60 | $-8.31 |
| Earnings Per Share Basic | $-1.81 | $-8.60 | $-8.31 |
| Temporary Equity Shares Outstanding | 0.00 | 17.2M | 12.9M |
| Temporary Equity Shares Issued | 0.00 | 17.2M | 12.9M |
| Temporary Equity Shares Authorized | 0.00 | 35.0M | 26.4M |
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 43.6M | 43.4M | 30.7M | 6.7M | 6.1M | 6.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 43.6M | 43.4M | 30.7M | 6.7M | 6.1M | 6.0M |
| Earnings Per Share Diluted | $-0.33 | $-0.39 | $-0.93 | $-1.46 | $-2.37 | $-2.07 |
| Earnings Per Share Basic | $-0.33 | $-0.39 | $-0.93 | $-1.46 | $-2.37 | $-2.07 |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | |||
| Temporary Equity Shares Issued | 0.00 | 0.00 | 0.00 | |||
| Temporary Equity Shares Authorized | 0.00 | 0.00 | 0.00 | |||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Provision For Doubtful Accounts | $40.0K | $70.0K | $46.0K |
| Investment Income Interest | $10.9M | $3.9M | $1.8M |
| Fair Value Adjustment Of Warrants | $12.5M | $13.4M | $10.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $16.4M | $6.4M | $5.7M |
| Stock Issued During Period Value Stock Options Exercised | $4.8M | $89.0K | $10.0K |
| Depreciation | $1.6M | $1.2M | $1.2M |
| Additional Paid In Capital | $657.1M | $51.3M | $26.4M |
| Capital Expenditures Incurred But Not Yet Paid | $129.0K | $20.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Provision For Doubtful Accounts | $24.0K | $0.00 | $0.00 | $0.00 | $27.0K | $17.0K |
| Investment Income Interest | $2.8M | $3.0M | $2.4M | $826.0K | $993.0K | $1.1M |
| Fair Value Adjustment Of Warrants | $0.00 | $0.00 | $12.5M | -$419.0K | $3.7M | $4.1M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.5M | $4.8M | $2.8M | $2.0M | $1.5M | $1.4M |
| Stock Issued During Period Value Stock Options Exercised | $2.7M | $42.0K | $98.0K | $46.0K | $6.0K | |
| Depreciation | $303.0K | $287.0K | ||||
| Additional Paid In Capital | $650.9M | $643.7M | $638.9M | |||
| Capital Expenditures Incurred But Not Yet Paid | $699.0K | $5.0K |
Most recent annual filing with the SEC: February 24, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.